Effect of Prasugrel sull'iperreattivita' bronchial and markers of airway inflammation in patients with chronic asthma: randomized crossover pilot study (Study PRINA). - PRINA

• Conditions: bronchial asthma; Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]

• Registration Number: EUCTR2010-023945-31-IT
• Lead Sponsor: AZIENDA OSPEDALIERA S. PAOLO (A.O. DI RILIEVO NAZIONALE)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-03-13
• Last Update Posted: 24 April 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Allergic asthma patients diagnosed with non-smokers defined
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1 - Pregnancy / breast-feeding, 2 - bleeding or high risk of bleeding 3 - Eta '> = 75 years 4 - Previous TIA or ischemic stroke, 5 - Other information antiagrregante platelet therapy.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified